Position in AZN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$27,097,835
-$2,173,360 QoQ
Shares Held
142,906
-3.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#198
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $264,283,617 across 13 Drug Manufacturers - General names. AZN ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
88,942 | $106,679,711 | |
| 2 | MRK |
Merck & Co., Inc.
|
248,349 | $31,912,846 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
142,906 | $27,097,835 | |
| 4 | ABBV |
AbbVie Inc.
|
105,545 | $26,559,343 | |
| 5 | JNJ |
Johnson & Johnson
|
95,241 | $24,188,356 | |
| 6 | AMGN |
Amgen Inc
|
56,484 | $20,453,986 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
236,011 | $13,598,953 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
70,944 | $8,963,064 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,097,835 | 142,906 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $29,271,195 | 148,419 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||